Skip to content
Adarza BioSystems
  • About Us
    • Our Team
    • Adarza Investors
    • Partnering
    • Careers
  • Contact Us
  • News & Events
    • AIR Technology
    • ZIVA™ Platform
    • Fixed Assays
    • Custom Assays
    • Resources
      • Publications and Downloads
      • COVID-19 Research
  • AIR Technology
  • ZIVA™ Platform
  • Fixed Assays
  • Custom Assays
  • Resources
    • Publications and Downloads
    • COVID-19 Research
Previous
Next

St. Louis Post-Dispatch: As Adarza scales up, St. Louis hopes for an important win

As Adarza scales up, St. Louis hopes for an important win.  By David Nicklaus

READ MORE

Supply Chain Manager

September 28, 2020

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

August 14, 2020

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

August 14, 2020

Adarza’s Ziva provides window into immune response to COVID-19 and other pathogens

June 24, 2020

St. Louis biotech startup raises $25M as it prepares for commercialization

February 6, 2020

Adarza raises $25 million, moves toward commercialization

February 5, 2020

NAVIGATE

  • AIR Technology
  • ZIVA Platform
  • Custom Assays
  • Publications and Downloads
  • COVID-19 Research
  • Contact Us
Menu
  • AIR Technology
  • ZIVA Platform
  • Custom Assays
  • Publications and Downloads
  • COVID-19 Research
  • Contact Us

READ THE LATEST

Supply Chain Manager

Using lasers to paint a high-definition picture of the body’s COVID-19 immune response

Adarza Shifts Focus to SARS-CoV-2 in Anticipation of Protein Biosensor Launch

JOIN OUR LIST

Copyright © 2021 Adarza BioSystems
All Rights Reserved | ADARZA BIOSYSTEMS is a registered trademark of Adarza Biosystems, Inc.